Relevance of Adalimumab Product Attributes to Patient Experience and Clinical Outcomes in the Biosimilar Era: A Narrative Review

   The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.  The above plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite). </p